Elisa Zuccarello

Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease”.

Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease

Biochemical Pharmacology(2020)10.1016/j.bcp.2020.113818

N/A

0DataRank · unranked

90 citations

Erica Acquarone, Elisa Calcagno, Elentina K. Argyrousi, Shi‐Xian Deng, Donald W. Landry +3 more

Optimizing metabolic stability of phosphodiesterase 5 inhibitors: Discovery of a potent N-(pyridin-3-ylmethyl)quinoline derivative targeting synaptic plasticity

Bioorganic & Medicinal Chemistry Letters(2023)10.1016/j.bmcl.2023.129409

N/A

0DataRank · unranked

6 citations

Hong Zhang, Erica Acquarone, Dang Pham, Anna Staniszewski, Shi‐Xian Deng +4 more

Discovery of Indole-Based PDE5 Inhibitors: Synthesis and Pharmacological Evaluation

ACS Medicinal Chemistry Letters(2025)10.1021/acsmedchemlett.5c00108

N/A

0DataRank · unranked

4 citations

Dang Pham, Param Shukla, Justin A. Edward, Reshmi John, Chun-Chun Li +6 more